Monaghan Medical Corporation Introduces an Intermediate-Size Mask
Anatomically designed mask will assist millions of Americans suffering from chronic lung disease PLATTSBURGH, NY (June 5, 2019) – Monaghan Medical Corporation (MMC) today introduced new product enhancements to continue […]
New published evidence reinforces the importance of device choice in asthma control
Two new publications build on previous evidence that not all devices are equally effective in delivering asthma control. PLATTSBURGH, N.Y., Jan. 31, 2018 — A recent article in Pulmonary Pharmacology […]
Significant reductions in costly pulmonary complications with use of drug-free device
Post-operative pulmonary complications (PPCs) are a major burden to the healthcare system. A new real-world study published in Pulmonary Therapy, indicates significant reductions in costs when using the AEROBIKA® oscillating positive expiratory […]
Monaghan’s drug-free Aerobika® device helps reduce the real-world impact of exacerbations in chronic obstructive pulmonary disease
SYRACUSE, NY, 21 February, 2017 – Monaghan Medical Corporation (MMC) today announced the publication of a study in Pulmonary Therapy showing treatment with the Aerobika® device can significantly reduce the recurrence of exacerbations of […]
New Study Shows Monaghan Medical’s Drug-Free Aerobika® Device Shows Promise for Treatment of Bronchiectasis
SYRACUSE, NY, January 12, 2017 – Monaghan Medical Corporation (MMC) today announced that the findings of a study published in the most recent issue of Academic Radiology shows that patients with […]
New Study Shows Monaghan Medical’s Drug-Free Aerobika® Device Reduces Acute Drug Usage And Costs Following COPD Exacerbations
Real-world study presented at CHEST 2016 Annual Meeting in Los Angeles SYRACUSE, NY, October 27, 2016 – Monaghan Medical Corporation (MMC) today announced that a new study presented to the […]